BioXcel Therapeutics Receives Permanent J-Code for IGALMI™ (dexmedetomidine) Sublingual Film from Centers for Medicare
USA Life Sciences Database,
New HCPCS Level II code J1105 to be effective January 1, 2024 NEW HAVEN, Conn., Oct.
New HCPCS Level II code J1105 to be effective January 1, 2024 NEW HAVEN, Conn., Oct.
GlobeNewswire 2023-10-30 NEW HAVEN, Conn., Oct. 30, 2023 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc.
New HCPCS Level II code J1105 to be effective January 1, 2024 NEW HAVEN, Conn., Oct.
Standardizes and improves product reimbursement process New HCPCS Level II code J1105 to be effective January 1, 2024 NEW HAVEN…